Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma

Mol Vis. 2008 Jul 4:14:1240-4.

Abstract

Purpose: Alterations of the plasmin system have been suggested to participate in the multifactorial pathogenesis of primary open-angle glaucoma (POAG). The main physiological inhibitor of the plasmin system is plasminogen activator inhibitor-1 (PAI-1), which leads to decreased degradation of extracellular material. Interestingly, elevated PAI-1 levels in the aqueous humor of patients with POAG have been reported. A common polymorphism within the promoter region (PAI-1 4G/5G) has previously been shown to reduce the gene transcription rate of PAI-1. The purpose of the present study was to investigate a hypothesized association between PAI-1 4G/5G and the presence of POAG in a Caucasian population.

Methods: The present case-control study comprised 212 unrelated patients with POAG and 212 healthy control subjects, matched for age and sex. Genotyping of PAI-1 4G/5G polymorphisms was done using polymerase chain reaction.

Results: Allelic frequencies and genotype distributions of PAI-1 4G/5G did not significantly differ between patients with POAG and control subjects (PAI-1 4G/5G: 29.7% versus 29.7%). Presence of the PAI-1 4G-allele was associated with a nonsignificant odds ratio of 0.98 (95% confidence interval: 0.74-1.30) for POAG.

Conclusions: Our data suggest that PAI-1 4G/5G itself is unlikely to be a major risk factor among Caucasian patients with POAG.

MeSH terms

  • Aged
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genotype
  • Glaucoma, Open-Angle / genetics*
  • Humans
  • Male
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Polymorphism, Single Nucleotide / genetics*

Substances

  • Plasminogen Activator Inhibitor 1